Aeolus Pharmaceuticals, Inc.
AOLS · OTC
9/30/2016 | 9/30/2015 | 9/30/2014 | 9/30/2013 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,155 | $94 | $1,517 | $869 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $750 | $1,585 | $1,559 | $370 |
| Inventory | $0 | $45 | $0 | $40 |
| Other Curr. Assets | $230 | $66 | $472 | $695 |
| Total Curr. Assets | $4,135 | $1,745 | $3,548 | $1,935 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $32 | $32 | $32 | $31 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $32 | $32 | $32 | $31 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $4,167 | $1,777 | $3,580 | $1,966 |
| Liabilities | – | – | – | – |
| Payables | $972 | $1,598 | $1,552 | $579 |
| Short-Term Debt | $0 | $1,002 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $22 | $443 | $682 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $972 | $2,622 | $1,995 | $1,261 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $972 | $2,622 | $1,995 | $1,261 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $5 | $5 | $5 |
| Common Stock | $1,520 | $1,359 | $1,359 | $1,346 |
| Retained Earnings | -$190,188 | -$186,630 | -$184,002 | -$183,922 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $191,863 | $184,421 | $184,223 | $183,276 |
| Total Equity | $3,195 | -$845 | $1,585 | $705 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,167 | $1,777 | $3,580 | $1,966 |
| Net Debt | -$3,155 | $908 | -$1,517 | -$869 |